Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement
Type
ArticleAuthor/s
Bousquet, JeanAkdis, Cezmi
Jutel, Marek
Bachert, Claus
Klimek, Ludger
Agache, Ioana
Ansotegui, Ignacio J.
Bedbrook, Anna
Bosnic-Anticevich, Sinthia
Canonica, Giorgio W.
Chivato, Tomas
Cruz, Alvaro A.
Czarlewski, Wienia
Del Giacco, Stefano
Du, Hui
Fonseca, Joao A.
Gao, Yadong
Haahtela, Tari
Hoffmann-Sommergruber, Karin
Ivancevich, Juan C.
Khaltaev, Nikolai
Knol, Edward F.
Kuna, Piotr
Larenas-Linnemann, Desiree
Mullol, Joaquim
Naclerio, Robert
Ohta, Ken
Okamoto, Y.
O'Mahony, Liam
Onorato, Gabrielle L.
Papadopoulos, Nikos G.
Pfaar, Oliver
Samolinski, Boleslaw
Schwarze, Jürgen
Toppila-Salmi, Sanna
Teresa Ventura, Maria
Valiulis, Arunas
Yorgancioglu, Arzu
Zuberbier, Torsten
Date
2020Licence
OtherFaculty/School
Faculty of Medicine and Health, Sydney Medical SchoolShare